Clinical Trials Logo

Clinical Trial Summary

Neutropenic enterocolitis (NEC) is a life-threatening complication of leukemic and solid tumors patients (pts) treated with chemotherapy (CHT) with high mortality rate up to 50-100%. Perforation occurs in 5%-10% of cases. Early diagnosis is crucial to start conservative medical management (CMM), which appears the optimal strategy for most cases. NEC should be always suspected in Neutropenic pts with abdominal pain, fever and diarrhea. Ultrasound (US) can be used to evaluate bowel-wall thickening (BWT). The objective of this study is to evaluate prospectively if US can detect early signs of NEC and guide a prompt treatment (CMM or surgical) and thus reduce mortality.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04813679
Study type Observational
Source Azienda Ospedaliero, Universitaria Pisana
Contact
Status Completed
Phase
Start date March 2007
Completion date January 2018

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02145923 - Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis Phase 1/Phase 2
Recruiting NCT04438278 - Profile Fecal Analysis of Neutropenic Enterocolitis
Recruiting NCT01699516 - Non-invasive Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft-vs-Host Disease N/A